Annual long term liabilities:
$1.36B+$249.41M(+22.51%)Summary
- As of today (June 25, 2025), CYTK annual total long term liabilities is $1.36 billion, with the most recent change of +$249.41 million (+22.51%) on December 31, 2024.
- During the last 3 years, CYTK annual long term liabilities has risen by +$831.77 million (+158.25%).
- CYTK annual long term liabilities is now at all-time high.
Performance
CYTK Long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly long term liabilities:
$1.37B+$13.37M(+0.98%)Summary
- As of today (June 25, 2025), CYTK quarterly total long term liabilities is $1.37 billion, with the most recent change of +$13.37 million (+0.98%) on March 1, 2025.
- Over the past year, CYTK quarterly long term liabilities has increased by +$255.35 million (+22.89%).
- CYTK quarterly long term liabilities is now at all-time high.
Performance
CYTK quarterly long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Long term liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
CYTK Long term liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +22.5% | +22.9% |
| 3 y3 years | +158.3% | +103.6% |
| 5 y5 years | +394.1% | +386.9% |
CYTK Long term liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +158.3% | at high | +131.0% |
| 5 y | 5-year | at high | +394.1% | at high | +386.9% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
CYTK Long term liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $1.37B(+1.0%) |
| Dec 2024 | $1.36B(+22.5%) | $1.36B(+1.3%) |
| Sep 2024 | - | $1.34B(+2.1%) |
| Jun 2024 | - | $1.31B(+17.7%) |
| Mar 2024 | - | $1.12B(+0.7%) |
| Dec 2023 | $1.11B(+6.7%) | $1.11B(+0.6%) |
| Sep 2023 | - | $1.10B(+5.2%) |
| Jun 2023 | - | $1.05B(+0.4%) |
| Mar 2023 | - | $1.04B(+0.5%) |
| Dec 2022 | $1.04B(+97.5%) | $1.04B(+2.2%) |
| Sep 2022 | - | $1.02B(+71.1%) |
| Jun 2022 | - | $593.46M(-11.8%) |
| Mar 2022 | - | $673.14M(+28.1%) |
| Dec 2021 | $525.60M(+35.0%) | $525.60M(+5.6%) |
| Sep 2021 | - | $497.65M(+2.4%) |
| Jun 2021 | - | $486.05M(+2.7%) |
| Mar 2021 | - | $473.29M(+21.6%) |
| Dec 2020 | $389.22M(+41.7%) | $389.22M(+31.1%) |
| Sep 2020 | - | $296.93M(+3.1%) |
| Jun 2020 | - | $287.88M(+2.2%) |
| Mar 2020 | - | $281.55M(+2.5%) |
| Dec 2019 | $274.73M(+68.5%) | $274.73M(+47.9%) |
| Sep 2019 | - | $185.75M(+2.5%) |
| Jun 2019 | - | $181.16M(+7.2%) |
| Mar 2019 | - | $168.96M(+3.6%) |
| Dec 2018 | $163.05M(+6.9%) | $163.05M(+4.0%) |
| Sep 2018 | - | $156.72M(+8.2%) |
| Jun 2018 | - | $144.78M(+2.1%) |
| Mar 2018 | - | $141.78M(-7.0%) |
| Dec 2017 | $152.52M(+258.7%) | $152.52M(+11.4%) |
| Sep 2017 | - | $136.92M(+1.7%) |
| Jun 2017 | - | $134.57M(+1.0%) |
| Mar 2017 | - | $133.19M(+213.2%) |
| Dec 2016 | $42.52M(+183.5%) | $42.52M(-6.7%) |
| Sep 2016 | - | $45.59M(+46.4%) |
| Jun 2016 | - | $31.14M(+1.7%) |
| Mar 2016 | - | $30.63M(+104.2%) |
| Dec 2015 | $15.00M(-12.0%) | $15.00M(+215.5%) |
| Sep 2015 | - | $4.75M(-45.6%) |
| Jun 2015 | - | $8.73M(-31.1%) |
| Mar 2015 | - | $12.68M(-25.6%) |
| Dec 2014 | $17.05M | $17.05M(+2896.3%) |
| Sep 2014 | - | $569.00K(+7.6%) |
| Jun 2014 | - | $529.00K(-59.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2014 | - | $1.31M(-36.0%) |
| Dec 2013 | $2.04M(+465.7%) | $2.04M(-37.1%) |
| Sep 2013 | - | $3.24M(-61.9%) |
| Jun 2013 | - | $8.52M(+1832.0%) |
| Mar 2013 | - | $441.00K(+22.2%) |
| Dec 2012 | $361.00K(>+9900.0%) | $361.00K(+135.9%) |
| Sep 2012 | - | $153.00K(+37.8%) |
| Jun 2012 | - | $111.00K(+94.7%) |
| Mar 2012 | - | $57.00K(+1800.0%) |
| Dec 2011 | $3000.00(-98.0%) | $3000.00(>+9900.0%) |
| Sep 2011 | - | $0.00(0.0%) |
| Jun 2011 | - | $0.00(-100.0%) |
| Mar 2011 | - | $34.00K(-77.6%) |
| Dec 2010 | $152.00K(-84.6%) | $152.00K(-50.8%) |
| Sep 2010 | - | $309.00K(-36.8%) |
| Jun 2010 | - | $489.00K(-32.5%) |
| Mar 2010 | - | $724.00K(-26.5%) |
| Dec 2009 | $985.00K(-93.3%) | $985.00K(-26.4%) |
| Sep 2009 | - | $1.34M(-23.8%) |
| Jun 2009 | - | $1.76M(-92.6%) |
| Mar 2009 | - | $23.66M(+59.8%) |
| Dec 2008 | $14.81M(-48.9%) | $14.81M(-18.9%) |
| Sep 2008 | - | $18.27M(-16.3%) |
| Jun 2008 | - | $21.83M(-14.1%) |
| Mar 2008 | - | $25.42M(-12.4%) |
| Dec 2007 | $29.01M(-21.2%) | $29.01M(-12.0%) |
| Sep 2007 | - | $32.97M(-11.1%) |
| Jun 2007 | - | $37.09M(-10.0%) |
| Mar 2007 | - | $41.20M(+11.9%) |
| Dec 2006 | $36.81M(+454.7%) | $36.81M(+453.2%) |
| Sep 2006 | - | $6.65M(+8.4%) |
| Jun 2006 | - | $6.14M(+3.4%) |
| Mar 2006 | - | $5.93M(-10.6%) |
| Dec 2005 | $6.64M(-30.2%) | $6.64M(-4.0%) |
| Sep 2005 | - | $6.91M(+0.7%) |
| Jun 2005 | - | $6.87M(-16.1%) |
| Mar 2005 | - | $8.19M(-13.8%) |
| Dec 2004 | $9.51M(-93.5%) | $9.51M(-2.6%) |
| Sep 2004 | - | $9.76M(-11.3%) |
| Jun 2004 | - | $11.01M(-92.4%) |
| Mar 2004 | - | $144.27M(-0.8%) |
| Dec 2003 | $145.45M(+35.4%) | $145.45M |
| Dec 2002 | $107.38M(+2946.3%) | - |
| Dec 2001 | $3.52M(+226.7%) | - |
| Dec 2000 | $1.08M | - |
FAQ
- What is Cytokinetics Incorporated annual total long term liabilities?
- What is the all time high annual long term liabilities for Cytokinetics Incorporated?
- What is Cytokinetics Incorporated annual long term liabilities year-on-year change?
- What is Cytokinetics Incorporated quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Cytokinetics Incorporated?
- What is Cytokinetics Incorporated quarterly long term liabilities year-on-year change?
What is Cytokinetics Incorporated annual total long term liabilities?
The current annual long term liabilities of CYTK is $1.36B
What is the all time high annual long term liabilities for Cytokinetics Incorporated?
Cytokinetics Incorporated all-time high annual total long term liabilities is $1.36B
What is Cytokinetics Incorporated annual long term liabilities year-on-year change?
Over the past year, CYTK annual total long term liabilities has changed by +$249.41M (+22.51%)
What is Cytokinetics Incorporated quarterly total long term liabilities?
The current quarterly long term liabilities of CYTK is $1.37B
What is the all time high quarterly long term liabilities for Cytokinetics Incorporated?
Cytokinetics Incorporated all-time high quarterly total long term liabilities is $1.37B
What is Cytokinetics Incorporated quarterly long term liabilities year-on-year change?
Over the past year, CYTK quarterly total long term liabilities has changed by +$255.35M (+22.89%)